Dealing with forehead acne? Here's what dermatologists recommend to treat and prevent pimples on your forehead, plus what ...
The open-label Phase 3 trial evaluated the safety of ASC40 (denifanstat) tablets in patients with moderate to severe acne over a 40-week period. Denifanstat is being developed by Ascletis for acne in ...
Back pain is one of the most common of all health complaints and, for nearly six million people, the pain is constant and ...
Scientists engineered dissolving needle patches with microscopic bubbles that deliver three acne drugs at once, vanishing in ...
“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Newspoint on MSN
Tulsi: Tulsi will clear up acne and make your face clean and radiant, just learn the right way to use it.
Tulsi Benefits: Tulsi, found in almost every Indian home, is not just a sacred plant, but also a treasure trove of natural ...
Almirall’s Seysara receives China NMPA approval for treatment of moderate-to-severe acne: Barcelona, Spain Saturday, January 31, 2026, 11:00 Hrs [IST] Almirall, S.A, a global ph ...
Neuroprotection in ischaemic stroke commonly means a treatment that results in the preservation of brain tissue in the setting of either focal or global ischaemia. The nominal focus on neuronal tissue ...
Acne risk for that group peaked during the first year following testosterone initiation, when transmasc individuals had more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results